Latest Tiziana Life Sciences News & Updates

See the latest news and media coverage for Tiziana Life Sciences. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Tiziana Life Sciences

Biotechnology company developing immunotherapies for neurodegenerative diseases

tizianalifesciences.com
Headquarters
London, United Kingdom
Company type
Public company
Number of employees
10–50

Latest news about Tiziana Life Sciences

Company announcements

  • Tiziana Life Sciences

    Tiziana announces publication of positive Foralumab data

    Intranasal anti-CD3 antibody attenuates Long COVID neuroinflammation and improves cognitive function.

  • Tiziana Life Sciences

    Tiziana announces nasal anti-CD3 improves aging-related cognition

    Preclinical data shows it dampens neuroinflammation, enhances hippocampal neurogenesis, and reduces cellular senescence. Executives highlight its potential for age-related cognitive impairment.

  • Tiziana Life Sciences

    Tiziana announces nasal foralumab biomarker data

    Data shows downregulation of CSF inflammation, upregulation of neuroprotective pathways, and correlation with reduced microglial activation on PET scans in na-SPMS patients with PIRA.

  • Tiziana Life Sciences

    Tiziana announces peer-reviewed publication of foralumab study results

    The open-label study in na-SPMS patients demonstrates EDSS stabilization, fatigue improvement, reduced microglial activation, and increased Tregs without serious adverse events.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Tiziana Life Sciences

Track Tiziana Life Sciences and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Tiziana Life Sciences competitors & trending companies

Browse news for competitors to Tiziana Life Sciences and other trending companies.